Author: healthadmin

A new study from University Hospitals Conner Hall Health reports that an insurance-supported integrative oncology program led to clinically meaningful improvements in cancer-related symptoms such as pain, stress, anxiety, depression, nausea, and fatigue. The results of this study highlight a scalable model that has the potential to provide future integrative therapies within routine oncology care. The results of this study were recently JCO Oncology Practice. The study, titled “Implementation and Patient-Reported Outcomes of an Insurance-Supported Integrative Oncology Symptom Management Program,” evaluated the first 16 months of the Conner Hall Health Integrative Oncology (CWHIO) Symptom Management Clinic. The clinic provided 1,924…

The 13th Annual Aging Research & Drug Discovery (ARDD) Conference, the world’s largest conference dedicated to longevity biotechnology, will be held at Harvard University’s David Rubenstein Treehouse from October 1-3, 2026. Marking the start of the high-profile Boston Longevity Week, this groundbreaking event is officially hosted by Insilico Medicine, which also anchors the conference as a Tier 1 sponsor alongside Eli Lilly. As longevity science rapidly moves from theoretical concepts to multibillion-dollar treatment pipelines, ARDD 2026 has established itself as the premier global nexus that brings together basic science, clinical research, major pharmaceutical companies, and institutional investors. Moving the conference…

In drug discovery, building complex molecules quickly is critical. Chemists increasingly want molecules with three-dimensional atomic structures because they have the potential to be more potent and selective in the body, but the additional chemical steps required to build that complexity are time-consuming and expensive. As it turns out, molecular complexity can be built in fewer steps using a surprisingly simple tool: an off-the-shelf blue LED light and off-the-shelf chemical building blocks familiar to second-year organic chemistry students. That’s according to a new study co-led by the University at Buffalo published Thursday (July 9). science. The researchers mixed familiar chemical…

The American Gastroenterological Association (AGA) today announced the launch of Nigel, an artificial intelligence (AI)-powered virtual assistant developed specifically for gastroenterology and hepatology. Built using AGA’s trusted clinical guidance and developed in collaboration with experts Dennis L. Shun, MD, MHS, Bradley C. Steady, MD, and Allie T. Strauss, MD, MIE, Nigel provides clinicians with fast, evidence-based answers designed for the complexities of gastrointestinal disease care. As gastroenterologists, we need answers we can trust in our practice. Nigel offers just that. With guideline-driven answers in seconds, you can have more confidence in your clinical decisions without wondering where the information…

To prevent viruses from making us sick or dying, whether it’s in individual cases of hepatitis B or the coronavirus pandemic, it’s important to understand how the proteins that viruses produce cause changes in our bodies that allow them to multiply. The new tools will greatly expand the scale at which researchers can study these proteins, and are expected to accelerate fundamental discoveries in virology, inform the development of new vaccines and treatments, and help protect humanity from emerging pathogens. The tool is called viral ORFeome and was described on July 2 as follows: cellis the largest of its kind,…

A new study led by researchers at the Icahn School of Medicine at Mount Sinai finds that while the total number of radiation oncology clinics in the United States appears to have stabilized in recent years, many individual treatment centers have quietly closed and others have opened. Closures have disproportionately affected rural and independent clinics, reducing access to life-saving radiotherapy for patients to receive life-saving cancer treatment closer to home. Published in International Journal of Radiation Oncology, Biology and Physics (10.1016/j.ijrobp.2026.06.3090 ), This study is the first national analysis to systematically track individual radiation oncology practices rather than physician groups…

New research presented today at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting explores an approach that could expand the potential of cell replacement therapy for type 1 diabetes by assessing whether immune-modified allogeneic insulin-producing cells can survive and function without chronic immunosuppression. This research addresses one of the central challenges of the field: overcoming immune rejection, which has limited the widespread use of islet- and stem cell-based replacement therapies for type 1 diabetes. “Type 1 diabetes is still primarily treated by replacing insulin, rather than replacing lost insulin-producing cells,” Sonya Schlöpfer, MD, of Cedars-Sinai Medical Center…

When archaeologists find adults and children buried together in medieval tombs, it is often assumed that they may have been members of the same family. A new study from Stockholm University published in Science Advances suggests otherwise. Researchers at Stockholm University analyzed the DNA of 142 people from the late Viking Age to the Middle Ages, including more than 60 children and adolescents buried in graves in Sigtuna near Stockholm, Västerhus in Jämtland, and Fjerkinge in Skåne. The results showed that even in cemeteries where high levels of kinship were detected, the existence of close biological relatives among people buried…

Can informing people about their genetic risk for obesity help them change their habits and lose excess weight? Study published in the journal obesity reviews Research by scientists, including those at SWPS University, shows that knowing your genes alone is not enough. Effective behavior change requires long-term, individualized support. Obesity is a global problem. By 2022, one in eight people worldwide will be living with the condition. In 2019 alone, being overweight was responsible for an estimated 5 million non-communicable disease deaths. The economic effect is also large. Experts predict that the global costs associated with obesity will reach $3…

According to a study published in *BMJ Mental Health*, older adults who have used cannabis do not appear to have faster cognitive decline or increased risk of dementia. The study also found no genetic evidence that cannabis use directly causes poor brain health later in life. As cannabis becomes available for both medical and recreational use, its popularity among older adults is increasing. This has led to concerns that cannabis may accelerate memory loss or increase the likelihood of developing dementia. Previous studies have yielded conflicting results, with some suggesting long-term cognitive impairment and others finding little evidence of lasting…